Compare Stocks: SENS, ENOV, DRTS, and BVS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.96 -0.5%	$13.69	$6.47 ▼ $15.89	$1.26B	0.64	404,262 shs	386,998 shs
DRTS Alpha Tau Medical	$13.16 +2.0%	$14.38	$3.43 ▼ $15.79	$1.19B	1.22	483,080 shs	324,635 shs
ENOV Enovis	$21.07 -2.4%	$20.31	$16.70 ▼ $34.28	$1.22B	1.37	1.39 million shs	954,280 shs
SENS Senseonics Holdings, Inc. Common Stock	$7.51 +1.5%	$9.18	$4.79 ▼ $10.64	$313.94M	1.02	599,836 shs	477,276 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	+12.48%	+10.65%	+26.78%	+110.41%
DRTS Alpha Tau Medical	0.00%	+7.08%	-10.90%	+5.28%	+225.74%
ENOV Enovis	0.00%	+7.40%	+15.27%	-22.12%	-35.71%
SENS Senseonics Holdings, Inc. Common Stock	0.00%	-3.35%	-27.37%	+54.53%	+750,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.96 -0.5%	$13.69	$6.47 ▼ $15.89	$1.26B	0.64	404,262 shs	386,998 shs
DRTS Alpha Tau Medical	$13.16 +2.0%	$14.38	$3.43 ▼ $15.79	$1.19B	1.22	483,080 shs	324,635 shs
ENOV Enovis	$21.07 -2.4%	$20.31	$16.70 ▼ $34.28	$1.22B	1.37	1.39 million shs	954,280 shs
SENS Senseonics Holdings, Inc. Common Stock	$7.51 +1.5%	$9.18	$4.79 ▼ $10.64	$313.94M	1.02	599,836 shs	477,276 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	+12.48%	+10.65%	+26.78%	+110.41%
DRTS Alpha Tau Medical	0.00%	+7.08%	-10.90%	+5.28%	+225.74%
ENOV Enovis	0.00%	+7.40%	+15.27%	-22.12%	-35.71%
SENS Senseonics Holdings, Inc. Common Stock	0.00%	-3.35%	-27.37%	+54.53%	+750,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	3.00	Buy	$16.80	12.30% Upside
DRTS Alpha Tau Medical	2.38	Hold	$15.40	17.02% Upside
ENOV Enovis	2.75	Moderate Buy	$37.25	76.83% Upside
SENS Senseonics Holdings, Inc. Common Stock	2.33	Hold	$13.00	73.10% Upside

Current Analyst Ratings Breakdown

Latest SENS, ENOV, DRTS, and BVS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/22/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/20/2026	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$16.00
10/16/2026	ENOV Enovis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/15/2026	DRTS Alpha Tau Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/12/2026	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$52.00 ➝ $34.00
10/8/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
10/7/2026	SENS Senseonics Holdings, Inc. Common Stock	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Equal Weight	$10.00
10/5/2026	ENOV Enovis	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$44.00
9/17/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/3/2026	DRTS Alpha Tau Medical	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$17.00 ➝ $30.00
9/2/2026	ENOV Enovis	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Market Outperform

(Data available from 10/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	2.21	$1.28 per share	11.73	$2.76 per share	5.42
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
ENOV Enovis	$2.30B	0.53	$26.66 per share	0.79	$26.09 per share	0.81
SENS Senseonics Holdings, Inc. Common Stock	$35.26M	8.90	N/A	N/A	$1.49 per share	5.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	19.43	16.81	1.91	9.36%	28.08%	9.82%	N/A
DRTS Alpha Tau Medical	-$42.63M	-$1.04	N/A	N/A	N/A	N/A	-138.12%	-81.68%	11/19/2026 (Estimated)
ENOV Enovis	-$1.18B	-$19.26	N/A	6.84	N/A	-47.96%	12.03%	4.91%	11/5/2026 (Estimated)
SENS Senseonics Holdings, Inc. Common Stock	-$69.11M	-$2.23	N/A	N/A	N/A	-225.09%	-165.80%	-80.14%	N/A

Latest SENS, ENOV, DRTS, and BVS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/19/2026	Q3 2026	DRTS Alpha Tau Medical	-$0.14	N/A	N/A	N/A	$0.24 million	N/A
11/5/2026	Q3 2026	ENOV Enovis	$0.7670	N/A	N/A	N/A	$557.15 million	N/A
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.1409	-$0.50	-$0.3591	-$0.50	$0.14 million	N/A
8/6/2026	Q2 2026	ENOV Enovis	$0.8470	$0.90	+$0.0530	-$0.02	$581.84 million	$582.78 million
8/6/2026	Q2 2026	SENS Senseonics Holdings, Inc. Common Stock	-$0.55	-$0.63	-$0.08	-$0.63	N/A	$14.48 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
SENS Senseonics Holdings, Inc. Common Stock	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
DRTS Alpha Tau Medical	0.15	11.09	7.79
ENOV Enovis	0.84	1.98	1.00
SENS Senseonics Holdings, Inc. Common Stock	0.62	6.74	6.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
DRTS Alpha Tau Medical	2.65%
ENOV Enovis	98.45%
SENS Senseonics Holdings, Inc. Common Stock	12.36%

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
DRTS Alpha Tau Medical	39.50%
ENOV Enovis	2.90%
SENS Senseonics Holdings, Inc. Common Stock	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	950	84.09 million	55.92 million	Optionable
DRTS Alpha Tau Medical	121	90.33 million	54.65 million	Optionable
ENOV Enovis	7,802	57.67 million	56.00 million	Optionable
SENS Senseonics Holdings, Inc. Common Stock	130	41.80 million	39.84 million	Optionable

SENS, ENOV, DRTS, and BVS Headlines

Recent News About These Companies

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

October 22 at 8:00 AM | globenewswire.com

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

October 21, 2026 | globenewswire.com

Barclays Begins Coverage on Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

October 7, 2026 | marketbeat.com

Bank of America Corp DE Acquires 394,465 Shares of Senseonics Holdings, Inc. Common Stock $SENS

October 1, 2026 | marketbeat.com

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Rated "Moderate Buy" by Sell-Side Brokerages

October 1, 2026 | marketbeat.com

Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal

September 29, 2026 | zacks.com

Senseonics Holdings stock steadies after 1-for-20 reverse split and recent volatility

September 19, 2026 | ad-hoc-news.deA

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

September 14, 2026 | globenewswire.com

Senseonics To Participate in Upcoming Institutional Investor Conferences

September 10, 2026 | globenewswire.com

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 13,953 Shares of Stock

August 21, 2026 | insidertrades.com

Senseonics sees activist investor take a major stake

August 17, 2026 | drugdeliverybusiness.comD

Senseonics Holdings, Inc. (SENS) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

August 6, 2026 | zacks.com

Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time

July 21, 2026 | globenewswire.com

Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?

June 29, 2026 | zacks.com

Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership

June 11, 2026 | zacks.com

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

June 6, 2026 | globenewswire.com

Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript

June 6, 2026 | seekingalpha.com

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

June 1, 2026 | globenewswire.com

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 22,686 Shares

May 14, 2026 | insidertrades.com

Senseonics Holdings, Inc. (NASDAQ:SENS) Q1 2026 Earnings Call Transcript

May 10, 2026 | insidermonkey.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SENS, ENOV, DRTS, and BVS Company Descriptions

Bioventus NASDAQ:BVS

$14.96 -0.08 (-0.53%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$14.95 -0.01 (-0.07%)

As of 10/23/2026 07:30 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Alpha Tau Medical NASDAQ:DRTS

$13.16 +0.26 (+2.02%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$13.05 -0.11 (-0.82%)

As of 10/23/2026 07:50 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Enovis NYSE:ENOV

$21.06 -0.53 (-2.43%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$21.08 +0.01 (+0.07%)

As of 10/23/2026 07:30 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

$7.51 +0.11 (+1.49%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$7.55 +0.04 (+0.55%)

As of 10/23/2026 07:51 PM Eastern

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SENS, ENOV, DRTS, and BVS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SENS, ENOV, DRTS, and BVS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SENS, ENOV, DRTS, and BVS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SENS, ENOV, DRTS, and BVS Company Descriptions

Bioventus NASDAQ:BVS

Alpha Tau Medical NASDAQ:DRTS

Enovis NYSE:ENOV

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SENS, ENOV, DRTS, and BVS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SENS, ENOV, DRTS, and BVS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SENS, ENOV, DRTS, and BVS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SENS, ENOV, DRTS, and BVS Company Descriptions

Bioventus NASDAQ:BVS

Alpha Tau Medical NASDAQ:DRTS

Enovis NYSE:ENOV

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools